MARKET

JNJ

JNJ

Johnson&Johnson
NYSE

Real-time Quotes | Nasdaq Last Sale

162.24
+1.85
+1.15%
After Hours: 162.00 -0.24 -0.15% 19:39 04/16 EDT
OPEN
161.34
PREV CLOSE
160.39
HIGH
162.51
LOW
160.56
VOLUME
9.05M
TURNOVER
--
52 WEEK HIGH
173.65
52 WEEK LOW
133.65
MARKET CAP
427.13B
P/E (TTM)
30.04
1D
5D
1M
3M
1Y
5Y
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Biotech stocks reversed course in the week ended April 16, with the sector rebounding along with the broader market. The week's news flow was fairly light. The American Association of Cancer Research's annual meeting provided a platform for oncology-focuse...
Benzinga · 8h ago
Moderna cuts UK COVID vaccine deliveries as pregnant women told mRNA jabs are safe
The Moderna jab, which works in a similar way to the Pfizer vaccine, uses synthetic messenger RNA (mRNA) technology that can be quickly tweaked to address new mutations of a virus.
Yahoo Finance UK · 9h ago
Bloomberg New Economy Newsletter: Vaccine Inequality Makes Everyone Lose
When the U.S. Centers for Disease Control and Prevention paused use of the Johnson & Johnson vaccine this week “out of an abundance of caution,” many vaccination sites simply switched out J&J doses for those of Pfizer-BioNTech and Moderna. For America, it ...
Bloomberg · 10h ago
Australia Posts Third AstraZeneca-Linked Death: Virus Update
Bloomberg · 16h ago
Cramer's week ahead: The impact of inflation and the reopening as earnings season accelerates
Next week marks the beginning of the real earnings season, "Mad Money" host Jim Cramer said.
CNBC.com · 22h ago
DJ J&J, Morgan Stanley, Coinbase: Stocks That Defined the Week
Dow Jones · 22h ago
Concerns over inflationary pressure on earnings will test stocks in the week ahead
Earnings will be the major focus in the week ahead, as investors home in on whether rising costs are squeezing margins and signaling inflationary pressures.
CNBC.com · 1d ago
Wall St Week Ahead-Tech retakes market lead as investors eye yields, earnings
reuters.com · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of JNJ. Analyze the recent business situations of Johnson&Johnson through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average JNJ stock price target is 185.44 with a high estimate of 201.00 and a low estimate of 153.00.
EPS
Institutional Holdings
Institutions: 3.89K
Institutional Holdings: 1.91B
% Owned: 72.61%
Shares Outstanding: 2.63B
TypeInstitutionsShares
Increased
1.42K
43.00M
New
339
13.70M
Decreased
1.14K
55.40M
Sold Out
60
2.48M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.98%
Pharmaceuticals & Medical Research
+0.89%
Key Executives
Chairman/Chief Executive Officer/Director
Alex Gorsky
Vice Chairman - Management/Chief Scientific Officer
Paulus Stoffels
Vice Chairman - Management
Joaquin Duato
Chief Financial Officer/Executive Vice President
Joseph Wolk
Chief Human Resource Officer/Executive Vice President
Peter Fasolo
Executive Vice President/General Counsel
Michael Ullmann
Executive Vice President
Ashley McEvoy
Executive Vice President
Ashley Mcevoy
Executive Vice President
Thibaut Mongon
Executive Vice President
Michael Sneed
Executive Vice President
Jennifer Taubert
Executive Vice President
Kathryn Wengel
Lead Director/Independent Director
Anne Mulcahy
Independent Director
Mary Beckerle
Independent Director
D. Scott Davis
Independent Director
Ian Davis
Independent Director
Jennifer Doudna
Independent Director
Marillyn Hewson
Independent Director
Hubert Joly
Independent Director
Mark McClellan
Independent Director
Mark Mcclellan
Independent Director
Charles Prince
Independent Director
A. Eugene Washington
Independent Director
Mark Weinberger
Independent Director
Nadja West
Independent Director
Ronald Williams
Declaration Date
Dividend Per Share
Ex-Div Date
01/04/2021
Dividend USD 1.01
02/22/2021
10/22/2020
Dividend USD 1.01
11/23/2020
07/20/2020
Dividend USD 1.01
08/24/2020
04/14/2020
Dividend USD 1.01
05/22/2020
01/02/2020
Dividend USD 0.95
02/24/2020
10/17/2019
Dividend USD 0.95
11/25/2019
07/15/2019
Dividend USD 0.95
08/26/2019
04/25/2019
Dividend USD 0.95
05/24/2019
01/02/2019
Dividend USD 0.9
02/25/2019
10/18/2018
Dividend USD 0.9
11/26/2018
07/16/2018
Dividend USD 0.9
08/27/2018
04/26/2018
Dividend USD 0.9
05/25/2018
01/02/2018
Dividend USD 0.84
02/26/2018
10/19/2017
Dividend USD 0.84
11/27/2017
07/17/2017
Dividend USD 0.84
08/25/2017
04/27/2017
Dividend USD 0.84
05/25/2017
01/03/2017
Dividend USD 0.8
02/24/2017
10/21/2016
Dividend USD 0.8
11/18/2016
07/18/2016
Dividend USD 0.8
08/19/2016
04/28/2016
Dividend USD 0.8
05/20/2016
01/04/2016
Dividend USD 0.75
02/19/2016
10/22/2015
Dividend USD 0.75
11/20/2015
07/20/2015
Dividend USD 0.75
08/21/2015
04/23/2015
Dividend USD 0.75
05/21/2015
01/05/2015
Dividend USD 0.7
02/20/2015
10/16/2014
Dividend USD 0.7
11/21/2014
07/21/2014
Dividend USD 0.7
08/22/2014
04/24/2014
Dividend USD 0.7
05/22/2014
01/02/2014
Dividend USD 0.66
02/21/2014
10/17/2013
Dividend USD 0.66
11/22/2013
07/15/2013
Dividend USD 0.66
08/23/2013
About JNJ
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Webull offers kinds of Johnson & Johnson stock information, including NYSE:JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.